Kimberly-Clark May Sell Assets to Save Its $40 Billion Kenvue Deal: Report
Kimberly-Clark prepares EU concessions to win approval for its $40B Kenvue deal, following Australian divestiture demands.
Stocks · News reference
Essity Strikes Agreement To Acquire Kenvue's Feminine Care Operations In Brazil For $284M
https://www.essity.com/media/press-release/essity-acquires-feminine-care-business-in-brazil/9dd724cebbb532f5/
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Here's My Pick for the Smartest High-Yield Dividend Stock to Buy Right Now
Kenvue (KVUE) is highlighted as a smart high-yield dividend stock with a 4.68% dividend yield and 64 consecutive years of dividend increases, making it a Dividend King. The company, spun off from Johnson & Johnson three years ago, generates steady revenue from recession-resilient consumer healthcare brands like Tylenol and Neutrogena. However, uncertainty exists due to a pending acquisition by Kimberly-Clark (KMB), another Dividend King with a 5.23% yield.
Shares of consumer staples companies are trading lower as elevated energy prices increase the chances of a Fed rate hike in September, which may slow consumer demand, boost borrowing costs and crimp margins.
Reported September 8, 2026: 'Tylenol Use In Pregnancy May Be Linked With Uterus, Ovary Changes In Daughters' - Reuters News